
Find out more about how timely shared decision-making discussions can help address unmet needs for women of childbearing age.
Professor Frank Behrens is Professor of Translational Rheumatology, Immunology and Inflammation Medicine and Head of the Inflammation Clinic, University Hospital, Frankfurt am Main, Germany, and Deputy Director, Fraunhofer Institute for Translational Medicine & Pharmacology (ITMP), Goethe University, Frankfurt am Main. He is also a member of the board of directors of the Fraunhofer Cluster of Excellence for Immune-Mediated Disease (CIMD).
Professor Behrens studied biology at the Johannes Gutenberg University in Mainz, Germany, before going on to study human medicine. He completed his doctorate in haematology and oncology before training in internal medicine and rheumatology.
Professor Behrens' main research interest is the pathophysiological understanding of spondyloarthritis, rheumatoid arthritis and mixed connected tissue disease. The focus is on understanding the links between these rheumatic conditions and associated skin and bowel diseases. The aim of the work is to develop new drug therapies and implement personalised treatment approaches using combined biomarker analyses and new imaging techniques. Since 2001, he has gained experience in clinical research and development as Principal Investigator, Chief Investigator and Managing Investigator. He is responsible for several investigator-initiated studies in rheumatic diseases.
Professor Behrens has published numerous articles in peer-reviewed journals and is author of several textbooks in the field of rheumatic diseases.
Professor Behrens is a member of various international committees and study groups such as the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Expert Panel Measures in Pulmonary Arterial Hypertension Related to Outcome of Systemic Sclerosis (EPOSS) and the Psoriatic Arthritis Genetic European Consortium (PAGE).
Accompany Dr Ann-Sophie De Craemer as she discusses management options for a patient with axSpA exhibiting few symptoms.
Work through the challenges in diagnosing suspected axSpA in two patient cases with Dr Michael Nissen and Dr Philipp Julian Bosch.
Join Dr Lykke Midtbøll Ørnbjerg as she explores the value of registry data for informing clinical practice in axSpA.
Find out more about how timely shared decision-making discussions can help address unmet needs for women of childbearing age.
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...